why choose us

First received: December 08, 2022

Clinical Trial: Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant

Study Status: Completed

Recruit Status: RECRUITING

Condition: Pre-Bronchiolitis Obliterans Syndrome

Study Type: INTERVENTIONAL


Official Title: A Phase 3, Open-label, Randomized, Standard of Care-controlled, Parallel Study Arm Study to Demonstrate Efficacy and Safety of ARINA-1 in the Prevention of Bronchiolitis Obliterans Syndrome (BOS) Prog

Brief Summary: The goal of this clinical trial is to compare ARINA-1 plus Standard of Care vs Standard of Care alone.The main question it aims to answer are:Evaluate the effectiveness of ARINA-1 in preventing bronchiolitis obliterans syndrome (BOS) progression in participants with a bilateral lung transplantTo evaluate the effectiveness of ARINA-1 on improving quality of life decline and preventing or delaying the use of augmented immunosuppression in participants with pre-BOS relative to SOC.Participants will have clinic visits…

Read more